Home › NDC Lookup › RxCUI directory › RxCUI 545206

Azacitidine 100 MG Injection [Vidaza] — RxCUI 545206

Name: Azacitidine 100 MG Injection [Vidaza] (RxCUI 545206)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 545206 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI545206

Official nameAzacitidine 100 MG Injection [Vidaza]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asVidaza 100 MG Injection

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)197 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Azacitidine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It treats certain types of myelodysplastic syndromes (MDS) in adults. These are bone marrow disorders where the marrow doesn't make healthy blood cells. Vidaza also has dosing for...
A healthcare professional gives it either as an injection under the skin or as an IV infusion. For adults it's usually once a day for 7 days, repeated about every 4 weeks. You'll t...
Nausea, vomiting, fever, diarrhea or constipation, and injection site redness or bruising are common. Low blood counts are also common, so you'll have regular blood tests.
Call for fever or signs of infection, unusual bleeding or bruising, yellow skin or eyes, confusion, or reduced urination. These could signal low blood counts or liver or kidney pro...

📖 Read our full Azacitidine Injection guide →

🕸️ Concept Web — How Azacitidine 100 MG Injection [Vidaza] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Azacitidine 100 MG Injection [Vidaza] RxCUI 545206 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Azacitidine 1251 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vidaza 545203 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Azacitidine Injection 1726497 SCDF
- Azacitidine Injectable Product 1154999 SCDG
- Azacitidine Injection [Vidaza] 1726500 SBDF
- Vidaza Injectable Product 1186581 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Azacitidine 100 MG Injection 485246 SCD
- Azacitidine 100 MG 1726496 SCDC
- Azacitidine 100 MG [Vidaza] 1726499 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Azacitidine 100 MG Injection SCD · 485246
Azacitidine 100 MG SCDC · 1726496
Azacitidine Injection SCDF · 1726497
Azacitidine Injectable Product SCDG · 1154999

Brand-Name Concepts

Azacitidine 100 MG [Vidaza] SBDC · 1726499
Azacitidine Injection [Vidaza] SBDF · 1726500
Vidaza Injectable Product SBDG · 1186581
Vidaza BN · 545203

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 545206 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
59572-0102-01	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (...	VIDAZA	Celgene Corporation	2004-07-05

Observed labelers: Celgene Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9025	Azacitidine injection	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.